Ceramide NanoLiposome
N/A
Report date: 2025/03/04 10:33:55
Base Information
Drug NameCeramide NanoLiposome
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPendreaBio Inc
China Registration ClassN/A
Develop Information
Active CompaniesPendreaBio Inc
Inactive CompaniesNational Cancer Institute
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A